ANI Pharmaceuticals, Inc. (ANIP)
73.34
+0.51
(+0.70%)
USD |
NASDAQ |
Aug 31, 16:00
73.34
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Cash from Operations (TTM) : 189.47M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 189.47M |
| March 31, 2026 | 208.61M |
| December 31, 2025 | 185.22M |
| September 30, 2025 | 170.72M |
| June 30, 2025 | 139.14M |
| March 31, 2025 | 80.74M |
| December 31, 2024 | 64.02M |
| September 30, 2024 | 92.90M |
| June 30, 2024 | 112.59M |
| March 31, 2024 | 115.80M |
| December 31, 2023 | 118.96M |
| September 30, 2023 | 69.82M |
| June 30, 2023 | 41.27M |
| March 31, 2023 | 9.163M |
| December 31, 2022 | -31.20M |
| September 30, 2022 | -38.99M |
| June 30, 2022 | -48.01M |
| March 31, 2022 | -36.29M |
| December 31, 2021 | 3.322M |
| September 30, 2021 | 9.798M |
| June 30, 2021 | 13.59M |
| March 31, 2021 | 34.22M |
| December 31, 2020 | 15.27M |
| September 30, 2020 | 25.78M |
| June 30, 2020 | 49.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 33.05M |
| December 31, 2019 | 45.63M |
| September 30, 2019 | 66.64M |
| June 30, 2019 | 53.01M |
| March 31, 2019 | 56.86M |
| December 31, 2018 | 65.50M |
| September 30, 2018 | 55.49M |
| June 30, 2018 | 64.41M |
| March 31, 2018 | 55.82M |
| December 31, 2017 | 39.42M |
| September 30, 2017 | 35.99M |
| June 30, 2017 | 19.99M |
| March 31, 2017 | 23.03M |
| December 31, 2016 | 27.47M |
| September 30, 2016 | 19.80M |
| June 30, 2016 | 28.95M |
| March 31, 2016 | 27.11M |
| December 31, 2015 | 17.26M |
| September 30, 2015 | 23.30M |
| June 30, 2015 | 17.23M |
| March 31, 2015 | 17.97M |
| December 31, 2014 | 22.03M |
| September 30, 2014 | 8.427M |
| June 30, 2014 | 2.637M |
| March 31, 2014 | 3.840M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Viatris, Inc. | 2.331B |
| Liquidia Corp. | 167.71M |
| Elanco Animal Health, Inc. | 617.00M |
| Harmony Biosciences Holdings, Inc. | 355.08M |
| Corcept Therapeutics, Inc. | 109.70M |